Preliminary immunological monitoring of first-in-human immunotherapy-trio of multivalent autophagosome vaccine, anti-GITR and anti-PD-1

Document Type

Presentation

Publication Date

12-3-2022

Keywords

oregon; chiles

Clinical Institute

Cancer

Specialty/Research Institute

Oncology

Specialty/Research Institute

Earle A. Chiles Research Institute

Comments

Presented at the Melanoma Bridge Annual Meeting; 2022 December 3.

This document is currently not available here.


Share

COinS